Patents Assigned to Pfizer Corporation
  • Intranasal administration of polypeptides in powdered form
    Patent number: 6815424
    Abstract: Pharmaceutical compositions of biologically active polypeptides in powder form suitable for nasal administration, comprising a therapeutically effective amount of a biologically active polypeptide and a water-soluble polysaccharide.
    Type: Grant
    Filed: December 23, 2002
    Date of Patent: November 9, 2004
    Assignee: Pfizer Corporation
    Inventors: Brian H. Vickery, Eric J. Benjamin, Cherng-Chyi Fu, Lynda M. Sanders